{"id":303412,"date":"2026-10-13T09:22:14","date_gmt":"2026-10-13T03:52:14","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=303412"},"modified":"2026-10-13T09:22:14","modified_gmt":"2026-10-13T03:52:14","slug":"branded-generic-rehydration-and-eye-care-stocks-forward-growth-shortlist","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/branded-generic-rehydration-and-eye-care-stocks-forward-growth-shortlist\/","title":{"rendered":"3 Branded Generic, Rehydration and Eye Care Stocks With a Strong Future Roadmap: Alkem Laboratories, FDC and Dr. Agarwal’s Health Care"},"content":{"rendered":"

Alkem Rs 5,205.00, P\/E 28.43. FDC Rs 341.40, P\/E 18.05. Dr. Agarwal’s Health Care Rs 475.20, P\/E 80.51. Closing prices of 12 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Branded generic, rehydration and eye care stocks with the clearest long-term roadmaps today include Alkem in branded generics and exports, FDC in oral rehydration products and eye and ear formulations and Dr. Agarwal’s Health Care in eye care hospitals and clinics. FY26 revenue growth was 13.7% at Alkem, 3.9% at FDC and 20.9% at Dr. Agarwal’s Health Care. P\/E stands at 28.43 for Alkem (industry 37.59), 18.05 for FDC (industry 37.59) and 80.51 for Dr. Agarwal’s Health Care (industry 62.79). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.<\/p>\n<\/p><\/div>\n

Branded generic, rehydration and eye care stocks give investors exposure to medicines and eye care that patients and doctors rely on. Prescription growth, hospital additions and margins decide how much of that demand turns into profit.<\/p>\n

This list covers three branded generic, rehydration and eye care stocks: Alkem Laboratories for branded generics and exports, FDC for oral rehydration products and eye and ear formulations and Dr. Agarwal’s Health Care for eye care hospitals and clinics. Every figure comes from the latest reported financials and the 12 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n